Condition

Healthy Adult Volunteers

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting1

Common interventions8

Lead sponsors shown3

Clinical trials

3 shown

Immun4Cure Cohort of Autoimmune DiseasesNCT07515638 · 2026-06-23

RECRUITING

Ultra-Processed Foods and Appetite Regulation: Acute Effects Across Body Mass Index CategoriesNCT06798220 · 2024-05-01

COMPLETED

Clinical Trial to Assess Bioequivalence of Lazertinib Between Two Formulations in Healthy Volunteers.NCT05162274 · 2021-11-30

COMPLETED

Common interventions

Blood test and principal collectionBIOLOGICAL1 ExaminationOTHER1 Lazertinib(G001)DRUG1 Lazertinib(G002)DRUG1 Optional collectionBIOLOGICAL1 Patient questionnairesOTHER1 Traditional BreakfastOTHER1 UPF BreakfastOTHER1

Leading sponsors

Ondokuz Mayıs University 1 University Hospital, Montpellier 1 Yuhan Corporation 1

Trial status mix

COMPLETED2

RECRUITING1

Phase mix

NA1

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.